Sign in
236: CONCENTRATIONS OF 6-THIOGUANINE NUCLEOTIDE AND USE OF ORAL METHOTREXATE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES CORRELATE WITH A BETTER PHARMACOKINECTIC PROFILE OF INFLIXIMAB BUT NOT OF VEDOLIZUMAB OR USTEKINUMAB: THE RESULTS OF THE COMBO-IBD STUDY
Journal article   Peer reviewed

236: CONCENTRATIONS OF 6-THIOGUANINE NUCLEOTIDE AND USE OF ORAL METHOTREXATE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES CORRELATE WITH A BETTER PHARMACOKINECTIC PROFILE OF INFLIXIMAB BUT NOT OF VEDOLIZUMAB OR USTEKINUMAB: THE RESULTS OF THE COMBO-IBD STUDY

Andres J. Yarur, Alexandra Bruss, Poonam Beniwal-Patel, Konstantinos Papamichail, Adam S. Cheifetz, Parakkal Deepak, Maria T. Abreu, Marla C. Dubinsky and Gil Melmed
Gastroenterology (New York, N.Y. 1943), Vol.162(7), pp.S-46-S-47
2022-05

Metrics

7 Record Views

Details